Credits: Canva
The US Food and Drug Administration has approved TNKase or Tenecteplase, which is a thrombolytic or clot-dissolving agent, for the treatment of acute ischemic stroke in adults.
Ischemic strokes happen when a blood clot blocks a blood vessel in your brain. It can cause permanent brain damage and death. If enough brain cells die, you can also lose the abilities or body functions those cells control. They are also the most common types of stroke, with 80% of all strokes being ischemic strokes.
It is delivered as a single five-second intravenous bolus, which is faster than the standard of care Activase or alteplase, which is administered as an intravenous bolus followed by a 60-minute infusion. The manufacturer of TNKase, Genetech said a new 25-mg vial configuration will also be available in the coming months.
The approval came at the backdrop of a study that compared TNKase to Activase in patients with acute ischemic stroke. These patients also presented with a disabling neurological deficit. Results show that TNKase was comparable to Activase in terms of efficacy and safety.
In the United States it self, it affects more than 795,000 people each year and is the leading cause of long-term disability. It is also the fifth leading cause of death. Since brain damage can happen if this progresses rapidly, one needs an immediate, fast-acting medical care.
TNKase thus provide a faster and simpler administration which can be critical for anyone. The chief medical officer and head of global product development at Genetech, Levi Garraway, MD., PhD., said, "Today's approval is a significant step forward and underscores our commitment to advancing stroke treatment options for patients."
Some of the most common symptoms include weakness or paralysis on one side of your face and body. You may also feel trouble speaking or have loss of speech, also known as aphasia. You may faced slurred or garbled speaking, also known as dysarthria. Other symptoms include loss of muscle control on one side of your face, or sudden worsening or loss of your senses, including vision, hearing, smell, taste, and touch.
While these are symptoms one has who is prone to this condition. However, often, many may confuse it with other illnesses. It is best to keep an eye out for warning signs. These could be looking out for yourself or your loved one. Note if there is a sudden loss of balance. Look out for sudden vision loss or changes in one or both eyes. Look for a droop on one or both sides of your face, especially when you smile. Raise both arms and see if one arm sags or drops in a way it usually does not. Note for your speech. Are you as fluent? Are you have trouble speaking? If you see any of such signs, start tracking it and talk to your healthcare provider.
Credit: AI image
The highly-anticipated Grand Theft Auto 6 (GTA 6) is expected to keep gamers glued to their screens. So questions about how much time people spend online and when entertainment becomes harmful are gaining attention.
In response to the question, a new report in Lancet Psychiatry Commission is now calling for coordinated global action to address problematic internet use, warning that gaming, social media, online pornography, gambling and even compulsive online shopping can become harmful when people do it uncontrollably.
The commission estimates that problematic internet use (PUI) may affect more than 10% of the global population, but estimates vary depending on definitions, measurement tools and populations studied.
It describes the issue as a growing public health concern as it poses serious consequences for mental health, relationships, education, work and overall well-being.
The experts are urging governments to do more than relying on individuals and families and instead hold digital platforms accountable for features designed to maximise engagement.
Also read: GTA 6: What Happens To Your Brain When You Spend Hours Gaming?
Spending several hours gaming does not automatically mean someone has a gaming disorder. The concern arises when online activities become difficult to control, take priority over other responsibilities and continue despite harmful consequences.
Problematic internet use covers several compulsive behaviours. These include online gaming and gambling disorders, problematic social media use, compulsive pornography use, online shopping and excessive health searching, which is referred to as cyberchondria.
The commission distinguishes between behaviours that are formally recognised as disorders and other forms of internet use that can still cause significant distress.
Gaming becomes concerning when a person repeatedly struggles to stop, neglects sleep or work, withdraws from relationships or continues playing despite clear negative consequences to their physical or mental health.
Also read: What Is Sad Nipple Syndrome? Could Hormones Trigger Sudden Sadness?
Researchers argue that the problem is not simply a lack of self-control. Digital platforms deliberately use features that encourage users to stay online longer and return repeatedly. These include:
The commission warns that artificial intelligence is making these systems sophisticated, allowing platforms to personalise engagement more effectively.
Problematic internet use has been linked with depression, anxiety, shorter attention span, sleep disturbances, loneliness, relationship conflict and poor productivity.
But mental health conditions may increase vulnerability to problematic internet use, while excessive or compulsive online behaviours may also worsen existing mental health problems. Researchers describe these relationships as bidirectional, meaning one may influence the other.
The commission also highlights exposure to pornography, online bullying, harmful content and the possible impact of AI-powered digital interactions on young people's emotional and social development.
The Lancet Commission is calling governments to install systems that place greater responsibility on technology companies.
Their recommendations include regulating harmful design features, improving transparency around algorithms, independent auditing of digital platforms, stronger protections for children and young people.
Credit: AI image
Autoimmune diseases are treated with therapies that suppress an overactive immune system that attacks the body’s healthy cells. So scientists are exploring if it is possible to ‘reset’ the immune system by removing the cells that attack the body.
A remarkable case from Germany may have made this possibility a reality. A 47-year-old woman suffering from three severe autoimmune diseases achieved remission after receiving a single infusion of experimental CAR-T cell therapy after years of unsuccessful treatments.
She no longer required daily blood transfusions and remained in remission nearly a year after therapy.
The case, published in the journal Med, highlighted the potential of CAR-T therapy beyond cancer, especially for severe autoimmune diseases that do not respond to existing treatment.
The woman had been living with three autoimmune conditions that caused her immune system to attack different components of her body.
She had been living with the conditions for more than a decade, and she had already undergone nine different treatments, including steroids, antibody therapies and immunosuppressive drugs, which did not offer any improvement.
Her illness had significantly affected her daily life, leaving her severely fatigued and unable to carry out normal activities.
CAR-T therapy involves collecting a patient's T cells, genetically modifying them to recognise a specific target and infusing them back into the body.
In this case, the researchers engineered the patient's T cells to target CD19, a protein found on B cells. B cells normally help protect the body by producing antibodies, but dysfunctional B cells can generate antibodies that mistakenly attack healthy tissues.
The engineered CAR-T cells were designed to eliminate these problematic B cells, allowing the immune system to rebuild its B-cell pool.
The patient began improving rapidly after treatment. Within seven days, she no longer required blood transfusions. Within approximately 25 days, her haemoglobin levels had returned to normal, her platelet counts stabilised and the antibodies related to the disease linked to blood clotting had fallen significantly. Her doctors reported complete remission across all three conditions.
Also read: Nick Jonas Opens Up About Living With Type 1 Diabetes For More Than 2 Decades: What Does It Entail
Immune reset is to essentially eliminate the dysfunctional immune cells responsible for driving disease rather than suppressing them.
After CAR-T treatment, the patient's B cells began returning approximately 322 days later. Most appeared to be naive B cells, meaning they had not previously been exposed to antigens and did not carry the same established immune memory of her autoimmune disease.
This suggests CAR-T therapy may have cleared the problematic B-cell population and allowed a new population to develop without immediately restarting the autoimmune attack.
Researchers believe this could offer something conventional therapies often struggle to do, which is prolonged remission without ongoing treatment.
While the patient's response was remarkable, this is a single case report and cannot establish how effective or safe CAR-T therapy would be for a larger population.
CAR-T treatment can cause serious complications like cytokine release syndrome, neurological toxicity, infections and prolonged immune suppression.
Although the patient did not experience severe cytokine release syndrome or neurological toxicity, she had some abnormalities during follow-up.
Researchers are now investigating CAR-T therapy in several autoimmune conditions, including lupus, systemic sclerosis and inflammatory muscle diseases.
Credit: AI image
Virginia reported a young child as its first case of measles-related death of 2026. Marking 48 years, the state had reported its last death due to measles in 1978.
According to the state’s health department, the child, who was four years old or maybe even younger, had tested positive for measles. The child’s vaccination status was not disclosed by the department, citing family privacy.
Also read: Measles Vaccine, Autism & Tylenol: RFK Jr's Most Controversial Health Claims
The latest Virginia fatality has added to the worst measles crisis the US is seeing in nearly three decades. The outbreak has cost the US its measles elimination status after the country maintained it for 26 years.
Virginia has reported 220 measles cases so far in 2026. It includes 40 among children aged four years old or younger and 75 among those age five to 12, according to the state health department’s data.
Among those cases, 179 are in unvaccinated individuals, 39 among people whose vaccination status was unknown and two in vaccinated individuals. This highlights the alarming decline in measles vaccination coverage across the country, which has fueled sustained transmission of the disease.
Frederic Bertley, immunologist and chief executive officer of the Center of Science and Industry said, “Virginia has not had a measles-related death since 1978.”
Bertley also said that the measles virus is both alarming and evidence that measles is becoming a growing problem for the US.
Virginia health officials have reported an increase in measles cases largely in the state’s central region. Buckingham county has reported 127 cases, the most in the state, while neighboring Charlotte county has recorded 34 cases.
Also read: Why Has CDC Challenged The Report Of Two Measles Deaths In Pennsylvania?
Virginia’s first measles-associated death has taken the national toll to 12. This comes days after US, Mexico, and Bolivia lost their measles elimination status.
Pennsylvania, the worst-hit state in the measles outbreak, has reported 12 deaths. Wisconsin, on the other hand, has had two deaths. New York reported its first measles-related death in 30 years.
The U.S. Centers for Disease Control and Prevention has reported more than 5,800 cases nationally in 2026, by far the most of any year since 1991.
According to the US Centers for Disease Control and Prevention (CDC), adults born in 1957 or later who do not have evidence of immunity should receive at least one dose of the MMR vaccine. But certain groups are recommended to receive two doses, separated by at least 28 days. These include:
People who have received two documented doses of the MMR vaccine, with the first administered at or after 12 months of age and the doses appropriately spaced, are considered protected for life.
© $2026 Times Horizon Private Limited